The effect of Kampo medicine for prevention of chronic subdural hematoma recurrence-prosepective study
Not Applicable
Recruiting
- Conditions
- chronic subdural hematoma
- Registration Number
- JPRN-UMIN000027747
- Lead Sponsor
- Cerebrovascular Research Institute, Eishokai Yoshida Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patient with severe dementia 2.Patient unable to take Kampo medicine 3.Bedridden patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence required operation
- Secondary Outcome Measures
Name Time Method Side effect